TerminatedPhase 1NCT02780583
Treatment of Macrophage Activation Syndrome (MAS) With Anakinra
Studying Macrophage activation syndrome
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- University of Alabama at Birmingham
- Principal Investigator
- Walter W Chatham, MDUniversity of Alabama Hospital
- Intervention
- kineret(drug)
- Enrollment
- 9 enrolled
- Eligibility
- 1 years · All sexes
- Timeline
- 2016 – 2024
Study locations (1)
- University of Alabama at Birmingham, Birmingham, Alabama, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT02780583 on ClinicalTrials.gov